Page not found

Search results

  1. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... Transfer Phase I grant for the development of this novel technology. “By vetting and facilitating the launch and growth ...

    sommers - 05/26/2021 - 10:39am

  2. Immunotherapies linked to specific heart complications

    ... of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel ... group that will help us characterize these novel and diverse side-effects of immunotherapies and identify those at ... of cardiovascular complications related to immune checkpoint inhibitors, linking these cases to REDCap to collect data on the cases. ...

    sommers - 02/21/2019 - 9:51am

  3. Tech Connect, Vol. 6, Issue 7: Collaboration seeks to develop new therapies for bone and other diseases

    ... Manager of Biotech Licensing in the  Vanderbilt Center for Technology Transfer & Commercialization , facilitated the agreement with La ... epithelial cell apoptosis  9,133,212   Inhibitors of hemeprotein-catalyzed lipid peroxidation 9,127,005   ...

    steelmk - 11/15/2016 - 4:11pm

  4. Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    ... partnership, which is facilitated by the  Center for Technology Transfer and Commercialization,  will promote the development of ... ideally suited to work with us to identify and characterize novel K ATP  channel activator candidates that could serve as the ...

    sommers - 02/25/2021 - 9:56am

  5. Tech Connect, Vol. 7, Issue 18: Vanderbilt Vaccine Center antibody effectively treats Marburg virus in monkeys

    ... The Center for Technology Transfer and Commercialization (CTTC) is working with AdvaMed , ... company to facilitate partnering discussions regarding novel therapeutic targets identified by Stephen Fesik of the Department of ...

    steelmk - 07/21/2017 - 3:31pm

  6. Tech Connect, Vol. 7, Issue 9: CTTC sponsors ACA Angel Insights Exchange

    ... of Toronto. She is a member of the Association of University Technology Managers. ... from the Mechanical Engineering Department regarding a novel minimally-invasive surgical device ...

    steelmk - 07/21/2017 - 3:04pm

  7. CTTC breaks records in rapid facilitation of COVID-19 related agreements

    ... to ending the global pandemic. Vanderbilt’s  Center for Technology Transfer & Commercialization  (CTTC) has accelerated its services ... would exist in a vacuum if not for the ability to scale novel findings from the lab to commercial organizations with experience in ...

    sommers - 07/10/2020 - 8:21am

  8. Zeno Power: Vanderbilt’s NSF I-Corps team makes an impact through innovation

    ... I-Corps Program, turning their STEM ideas and research into novel inventions that  improve health care ,  strengthen cybersecurity , ... or refueling. Ideal for use in remote, austere settings, the technology works by converting recycled nuclear waste—decaying ...

    sommers - 04/12/2021 - 10:57am

  9. Vanderbilt collaborates with Boehringer Ingelheim for difficult-to-treat cancers

    ... These discoveries raise the prospect of developing novel cancer treatment options based on molecules that are able to block this ... are very encouraged by the successful identification of inhibitors of KRAS in our alliance with Professor Fesik and his team at ...

    steelmk - 03/10/2017 - 10:58am

  10. Tech Connect, Vol. 6, Issue 4: Vanderbilt University and La Jolla Pharmaceutical Company enter Exclusive Research and License Agreement

    ... to research and develop small-molecule BMP type-I receptor inhibitors designed to aid in treatment of rare genetic disorders. Click ... equipment supplier regarding Doppler Ultrasound Phantom technology developed by Jared Grice from the Department of Radiology ...

    steelmk - 11/15/2016 - 4:19pm